HSA

Hussman Strategic Advisors Portfolio holdings

AUM $462M
1-Year Est. Return 3.97%
This Quarter Est. Return
1 Year Est. Return
+3.97%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$438M
AUM Growth
+$25.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
312
New
Increased
Reduced
Closed

Top Buys

1
+$8.49M
2
+$4.71M
3
+$4.1M
4
GL icon
Globe Life
GL
+$3.92M
5
EPAM icon
EPAM Systems
EPAM
+$3.71M

Top Sells

1
+$4.92M
2
+$4.65M
3
+$3.84M
4
CNXC icon
Concentrix
CNXC
+$3.51M
5
BG icon
Bunge Global
BG
+$3.21M

Sector Composition

1 Healthcare 22.59%
2 Technology 17.67%
3 Materials 16.79%
4 Financials 11.81%
5 Consumer Staples 11.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRB icon
251
H&R Block
HRB
$5.6B
– –
-21,000
HROW icon
252
Harrow
HROW
$1.51B
– –
-21,000
INGR icon
253
Ingredion
INGR
$6.84B
– –
-12,600
JBLU icon
254
JetBlue
JBLU
$1.52B
– –
-210,000
JKS
255
JinkoSolar
JKS
$1.4B
– –
-126,000
KNTK icon
256
Kinetik
KNTK
$2.21B
– –
-42,000
KO icon
257
Coca-Cola
KO
$306B
– –
-21,000
KR icon
258
Kroger
KR
$44.2B
– –
-31,500
KSS icon
259
Kohl's
KSS
$1.88B
– –
-147,000
KTB icon
260
Kontoor Brands
KTB
$4B
– –
-42,000
LEU icon
261
Centrus Energy
LEU
$4.55B
– –
-31,500
LNTH icon
262
Lantheus
LNTH
$3.52B
– –
-21,000
LUNR icon
263
Intuitive Machines
LUNR
$1.14B
– –
-147,000
META icon
264
Meta Platforms (Facebook)
META
$1.54T
– –
-1,050
MTCH icon
265
Match Group
MTCH
$7.62B
– –
-31,500
NBIX icon
266
Neurocrine Biosciences
NBIX
$14.4B
– –
-25,200
NRIX icon
267
Nurix Therapeutics
NRIX
$1.3B
– –
-42,000
NTAP icon
268
NetApp
NTAP
$21.8B
– –
-10,500
NVAX icon
269
Novavax
NVAX
$1.13B
– –
-168,000
NVCR icon
270
NovoCure
NVCR
$1.27B
– –
-105,000
OGN icon
271
Organon & Co
OGN
$1.96B
– –
-105,000
OLLI icon
272
Ollie's Bargain Outlet
OLLI
$7.64B
– –
-21,000
OUST icon
273
Ouster
OUST
$1.32B
– –
-63,000
OXM icon
274
Oxford Industries
OXM
$520M
– –
-8,400
PFE icon
275
Pfizer
PFE
$142B
– –
-63,000
9 10
11
12 13